Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: Results from the PHOENIX 1 trial through up to 3 years

A. B. Kimball*, K. B. Gordon, S. Fakharzadeh, N. Yeilding, P. O. Szapary, B. Schenkel, C. Guzzo, S. Li, K. A. Papp

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

117 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: Results from the PHOENIX 1 trial through up to 3 years'. Together they form a unique fingerprint.

Nursing and Health Professions

INIS

Pharmacology, Toxicology and Pharmaceutical Science